{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T00:34:45Z","timestamp":1792715685714,"version":"4.5.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T00:00:00Z","timestamp":1771459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T00:00:00Z","timestamp":1774396800000},"content-version":"vor","delay-in-days":34,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Neurotrophins such as nerve growth factor (NGF) and glial cell line-derived neurotrophic factor (GDNF) are crucial for neuronal maintenance and immune regulation. However, their dynamics during coronavirus disease 2019 (COVID-19) remain unclear. In this prospective study, 30 hospitalized patients with PCR-confirmed COVID-19 were evaluated longitudinally. Serum NGF, GDNF, and conventional inflammatory markers (CRP, ESR, fibrinogen, ferritin, D-dimer, LDH, hematological counts) were measured on Day 1, Day 4, and at discharge. A control group of 37 healthy individuals was included for cross-sectional comparison. Both NGF and GDNF levels were significantly lower in COVID-19 patients at admission compared with healthy individuals. NGF showed a modest early decline from Day 1 to Day 4, followed by partial recovery at discharge, whereas GDNF remained stable throughout hospitalization. Inflammatory markers demonstrated expected clinical trajectories: CRP, ESR, LDH, and fibrinogen decreased during recovery, while WBC, neutrophils, and platelets increased. Ferritin and D-dimer showed no meaningful temporal changes. NGF appears to reflect acute neuroimmune activation in COVID-19 and may serve as a dynamic biomarker of early inflammatory resolution. Conversely, GDNF remained persistently suppressed, suggesting a distinct role in chronic neuroimmune regulation. These findings highlight NGF and GDNF as potential targets for monitoring and modulating neuroimmune responses in COVID-19 and other inflammation-driven conditions.<\/jats:p>","DOI":"10.1038\/s41598-026-40236-9","type":"journal-article","created":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T08:05:45Z","timestamp":1771488345000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Altered NGF and GDNF levels reveal neuroimmune dysregulation in COVID-19 patients"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4387-6929","authenticated-orcid":false,"given":"Lale Saka","family":"Baraz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6572-0277","authenticated-orcid":false,"given":"Evrim","family":"Ataca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0897-2819","authenticated-orcid":false,"given":"Nur Duzen","family":"Oflas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5618-9525","authenticated-orcid":false,"given":"Seyma Canavar","family":"Kosali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5976-9517","authenticated-orcid":false,"given":"Busra","family":"Usta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1160-9340","authenticated-orcid":false,"given":"Alihan","family":"Oral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6148-5142","authenticated-orcid":false,"given":"Mustafa","family":"Cihangiroglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6842-2918","authenticated-orcid":false,"given":"Metin","family":"Ozgen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1852-7981","authenticated-orcid":false,"given":"Demet Yalcin","family":"Kehribar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,19]]},"reference":[{"key":"40236_CR1","doi-asserted-by":"publisher","first-page":"865","DOI":"10.3390\/cells9040865","volume":"9","author":"L Morel","year":"2020","unstructured":"Morel, L., Domingues, O., Zimmer, J. & Michel, T. Revisiting the role of neurotrophic factors in inflammation. Cells 9, 865 (2020).","journal-title":"Cells"},{"key":"40236_CR2","first-page":"907","volume":"13","author":"C Petrella","year":"2024","unstructured":"Petrella, C. et al. Nerve growth factor and Brain-Derived neurotrophic factor in COVID-19. Biology (Basel). 13, 907 (2024).","journal-title":"Biology (Basel)"},{"key":"40236_CR3","first-page":"174","volume":"29","author":"M Ozgen","year":"2025","unstructured":"Ozgen, M., Baraz, L. S. & Usta, B. Yalcin Kehribar, D. NGF and GDNF in Beh\u00e7et\u2019s disease: linking neurotrophic factors to immune regulation. Eur. Rev. Med. Pharmacol. Sci. 29, 174\u2013179 (2025).","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"40236_CR4","doi-asserted-by":"publisher","first-page":"9112","DOI":"10.3390\/ijms22179112","volume":"22","author":"P Liu","year":"2021","unstructured":"Liu, P., Li, S. & Tang, L. Nerve growth factor: A potential therapeutic target for lung diseases. Int. J. Mol. Sci. 22, 9112 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"40236_CR5","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/S0761-8425(04)71290-5","volume":"21","author":"V Freund","year":"2004","unstructured":"Freund, V. & Frossard, N. Le facteur de croissance des Nerfs (NGF) Dans l\u2019inflammation et l\u2019asthme. Rev. Mal Respir. 21, 328\u2013342 (2004).","journal-title":"Rev. Mal Respir"},{"key":"40236_CR6","first-page":"2127","volume":"36","author":"A Lambiase","year":"1995","unstructured":"Lambiase, A. et al. Increased plasma levels of nerve growth factor in vernal keratoconjunctivitis and relationship to conjunctival mast cells. Invest. Ophthalmol. Vis. Sci. 36, 2127\u20132132 (1995).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"40236_CR7","doi-asserted-by":"publisher","first-page":"e1186","DOI":"10.1016\/j.ijid.2013.07.006","volume":"17","author":"A Chiaretti","year":"2013","unstructured":"Chiaretti, A. et al. Interleukin and neurotrophin up-regulation correlates with severity of H1N1 infection in children: a case\u2013control study. Int. J. Infect. Dis. 17, e1186\u2013e1193 (2013).","journal-title":"Int. J. Infect. Dis."},{"key":"40236_CR8","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.3390\/diagnostics12051162","volume":"12","author":"C Petrella","year":"2022","unstructured":"Petrella, C. et al. Serum NGF and BDNF in Long-COVID-19 adolescents: A pilot study. Diagnostics 12, 1162 (2022).","journal-title":"Diagnostics"},{"key":"40236_CR9","doi-asserted-by":"publisher","first-page":"5817","DOI":"10.3390\/ijms23105817","volume":"23","author":"K Bohmwald","year":"2022","unstructured":"Bohmwald, K. et al. Neurotrophin signaling impairment by viral infections in the central nervous system. Int. J. Mol. Sci. 23, 5817 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"40236_CR10","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/nrn812","volume":"3","author":"MS Airaksinen","year":"2002","unstructured":"Airaksinen, M. S. & Saarma, M. The GDNF family: Signalling, biological functions and therapeutic value. Nat. Rev. Neurosci. 3, 383\u2013394 (2002).","journal-title":"Nat. Rev. Neurosci."},{"key":"40236_CR11","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.4269\/ajtmh.20-1536","volume":"104","author":"A Rahman","year":"2021","unstructured":"Rahman, A. et al. Hematological abnormalities in COVID-19: A narrative review. Am. J. Trop. Med. Hyg. 104, 1188\u20131201 (2021).","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"40236_CR12","doi-asserted-by":"crossref","unstructured":"Kalaiselvan, P., Yingchoncharoen, P., Thongpiya, J., Motes, A. & Nugent, K. COVID-19 infections and inflammatory markers in patients hospitalized during the first year of the pandemic. J Prim. Care Community Health 14, (2023).","DOI":"10.1177\/21501319231206911"},{"key":"40236_CR13","doi-asserted-by":"crossref","unstructured":"Cheng, L. et al. Ferritin in the coronavirus disease 2019 (COVID-19): A systematic review and meta\u2010analysis. J Clin. Lab. Anal 34, (2020).","DOI":"10.1002\/jcla.23618"},{"key":"40236_CR14","doi-asserted-by":"publisher","first-page":"e192","DOI":"10.1016\/S1473-3099(20)30483-7","volume":"20","author":"JC Marshall","year":"2020","unstructured":"Marshall, J. C. et al. A minimal common outcome measure set for COVID-19 clinical research. Lancet Infect. Dis. 20, e192\u2013e197 (2020).","journal-title":"Lancet Infect. Dis."},{"key":"40236_CR15","doi-asserted-by":"publisher","first-page":"175","DOI":"10.3758\/BF03193146","volume":"39","author":"F Faul","year":"2007","unstructured":"Faul, F., Erdfelder, E., Lang, A. G. & Buchner, A. G*Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav. Res. Methods. 39, 175\u2013191 (2007).","journal-title":"Behav. Res. Methods"},{"key":"40236_CR16","doi-asserted-by":"publisher","first-page":"294","DOI":"10.2174\/1570159X13666150403231920","volume":"13","author":"L Aloe","year":"2015","unstructured":"Aloe, L., Rocco, M., Balzamino, B. & Micera, A. Nerve growth factor: A focus on neuroscience and therapy. Curr. Neuropharmacol. 13, 294\u2013303 (2015).","journal-title":"Curr. Neuropharmacol."},{"key":"40236_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/jir.2021.0116","volume":"42","author":"H Chen","year":"2022","unstructured":"Chen, H., Han, T., Gao, L. & Zhang, D. The involvement of glial Cell-Derived neurotrophic factor in inflammatory bowel disease. J. Interf Cytokine Res. 42, 1\u20137 (2022).","journal-title":"J. Interf Cytokine Res."},{"key":"40236_CR18","doi-asserted-by":"crossref","unstructured":"Turkeri, O. N. et al. Serum glial-derived neurotrophic factor and nerve growth factor levels in patients with COVID-19. \u010cesk\u00e1 Slov. Neurol. Neurochir 86\/119, (2023).","DOI":"10.48095\/cccsnn2022128"},{"key":"40236_CR19","doi-asserted-by":"publisher","first-page":"1085988","DOI":"10.3389\/fmed.2023.1085988","volume":"10","author":"YJ Lai","year":"2023","unstructured":"Lai, Y. J. et al. Biomarkers in long COVID-19: A systematic review. Front. Med. 10, 1085988 (2023).","journal-title":"Front. Med."},{"key":"40236_CR20","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1016\/j.joca.2013.06.004","volume":"21","author":"MF Seidel","year":"2013","unstructured":"Seidel, M. F., Wise, B. L. & Lane, N. E. Nerve growth factor: an update on the science and therapy. Osteoarthr. Cartil. 21, 1223\u20131228 (2013).","journal-title":"Osteoarthr. Cartil."},{"key":"40236_CR21","doi-asserted-by":"crossref","unstructured":"Kotliarova, A. & Sidorova, Y. A. Glial cell Line-Derived neurotrophic factor family Ligands, players at the interface of neuroinflammation and neuroprotection: focus onto the glia. Front Cell. Neurosci 15, (2021).","DOI":"10.3389\/fncel.2021.679034"},{"key":"40236_CR22","doi-asserted-by":"publisher","first-page":"965","DOI":"10.3390\/cimb46020062","volume":"46","author":"G Ferraguti","year":"2024","unstructured":"Ferraguti, G. et al. Nerve growth factor and the role of inflammation in tumor development. Curr. Issues Mol. Biol. 46, 965\u2013989 (2024).","journal-title":"Curr. Issues Mol. Biol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-40236-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-40236-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-40236-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T09:12:00Z","timestamp":1774429920000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-40236-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,19]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["40236"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-40236-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,19]]},"assertion":[{"value":"1 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9919"}}